
    
      The study duration is approximately up to 110 weeks (run-in period [if needed]: up to 4 weeks
      [+2 days], screening period: up to 2 weeks [+5 days], double-blind treatment period: 24
      weeks, open label treatment period: 80 weeks).
    
  